1. Home
  2. MRVI vs PDLB Comparison

MRVI vs PDLB Comparison

Compare MRVI & PDLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • PDLB
  • Stock Information
  • Founded
  • MRVI 2014
  • PDLB 1960
  • Country
  • MRVI United States
  • PDLB United States
  • Employees
  • MRVI 560
  • PDLB N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • PDLB
  • Sector
  • MRVI Health Care
  • PDLB
  • Exchange
  • MRVI Nasdaq
  • PDLB Nasdaq
  • Market Cap
  • MRVI 350.1M
  • PDLB 328.3M
  • IPO Year
  • MRVI 2020
  • PDLB 2017
  • Fundamental
  • Price
  • MRVI $2.42
  • PDLB $14.86
  • Analyst Decision
  • MRVI Hold
  • PDLB
  • Analyst Count
  • MRVI 10
  • PDLB 0
  • Target Price
  • MRVI $5.84
  • PDLB N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • PDLB 33.5K
  • Earning Date
  • MRVI 08-11-2025
  • PDLB 10-29-2025
  • Dividend Yield
  • MRVI N/A
  • PDLB N/A
  • EPS Growth
  • MRVI N/A
  • PDLB 83.78
  • EPS
  • MRVI N/A
  • PDLB 0.71
  • Revenue
  • MRVI $219,830,000.00
  • PDLB $90,513,000.00
  • Revenue This Year
  • MRVI N/A
  • PDLB $10.97
  • Revenue Next Year
  • MRVI $7.23
  • PDLB $8.59
  • P/E Ratio
  • MRVI N/A
  • PDLB $20.85
  • Revenue Growth
  • MRVI N/A
  • PDLB 15.50
  • 52 Week Low
  • MRVI $1.67
  • PDLB $10.74
  • 52 Week High
  • MRVI $9.60
  • PDLB $15.06
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • PDLB 60.70
  • Support Level
  • MRVI $2.28
  • PDLB $13.96
  • Resistance Level
  • MRVI $2.47
  • PDLB $14.99
  • Average True Range (ATR)
  • MRVI 0.14
  • PDLB 0.32
  • MACD
  • MRVI -0.01
  • PDLB 0.03
  • Stochastic Oscillator
  • MRVI 27.45
  • PDLB 81.08

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Share on Social Networks: